Skip to content

Clinical Study for the Effect of Baduanjin on Motor Rehabilitation of Stroke Patients

Clinical Study for the Effect of Baduanjin on Motor Rehabilitation of Stroke Patients

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020899
Enrollment
Unknown
Registered
2019-01-22
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral apoplexy

Interventions

Group 1:Baduanjin+regular therapy

Sponsors

North Hospital of Huashan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 35 to 75 years; (2) It conforms to the diagnostic criteria of "stroke" formulated by the 4th National Academic Conference on Cerebrovascular Diseases and has a definite diagnosis by cranial CT or MRI. The course of the disease is more than 2 weeks, and the vital signs are stable within 6 months; (3) Unilateral hemiplegia, able to walk independently (using/not using walker) without obvious abnormalities in limb depth and shallow sensation; Brunnstrom grade IV or above of lower extremities; standing balance up to grade 2 or more; (4) Hearing comprehension is basically normal and can cooperate with treatment and evaluation; (5) Willing to obey the guidance and have a good desire for rehabilitation and good family support; (6) I and my family are willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Congestive heart failure; (2) Active liver disease, hepatorenal insufficiency; (3) Malignant tumors; (4) MMSE score of patients with psychiatric disorders or severe cognitive impairment was less than 25; (5) The patients with severe infection, rheumatism or rheumatoid arthritis have obvious joint deformity. (6) Deaf-mute; (7) The blood pressure of patients with uncontrolled hypertension was higher than 180/100mmHg; (8) Those who can not cooperate with fixed-point long-term treatment or those who can not be followed up in other provinces or cities; (9) Participated in other clinical researchers during the same period.

Design outcomes

Primary

MeasureTime frame
Berg Blance Scale;the Barthelindex of ADL;Fugl-Meyer;6-minute walk test;balance of performance monitor;

Countries

China

Contacts

Public ContactXie Beijing

North Hospital of Huashan Hospital Affiliated to Fudan University

jcqk10@126.con+86 13564521166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026